STING1 and cancer: This aberrant dsDNA activates the cGAS-STING pathway in cancer cells and promotes production of IFNβ and pro-inflammatory chemokines, which contribute to the recruitment of dendritic cells and immune effector cells into tumor, thereby eliciting an anti-tumor immune response 11.